The Venture Codex Logo

The Venture Codex

Thairm Bio

3a Dublin Meuse, Edinburgh, EH3 6NW, United Kingdom

Overview

Invests in early-stage life science companies for breakthrough treatments.

Deals · 12mo

1

Stage focus

Seed
Series A

Geographic focus

United Kingdom
United States

Sector focus

—

Investment portfolio

10rounds
NAMEDATESIZE
EnteroBiotix
May 2026Led
$26 MOther Equity
3Daughters
Jul 2024Participated
$5 MSeed
EnteroBiotix
Apr 2024Participated
$34 MOther Equity
3Daughters
Jan 2024Led
$2 MSeed
Microplate Dx
Sep 2023Participated
$3 MSeed
Pneumagen
Jun 2023Participated
$10 MOther Equity
Phlo
Feb 2023Led
$12 MSeries A
Pneumagen
Jan 2022Led
$5 MOther Equity
EnteroBiotix
Sep 2021Led
$21 MSeries A
Pneumagen
May 2020Led
$5 MOther Equity
EnteroBiotix
May 2026Led
$26 MOther Equity
3Daughters
Jul 2024Participated
$5 MSeed
EnteroBiotix
Apr 2024Participated
$34 MOther Equity
3Daughters
Jan 2024Led
$2 MSeed
Microplate Dx
Sep 2023Participated
$3 MSeed
Pneumagen
Jun 2023Participated
$10 MOther Equity
Phlo
Feb 2023Led
$12 MSeries A
Pneumagen
Jan 2022Led
$5 MOther Equity
EnteroBiotix
Sep 2021Led
$21 MSeries A
Pneumagen
May 2020Led
$5 MOther Equity
10
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Thairm Bio: 10 funding rounds are recorded in the selected participation categories.All available history.
Thairm Bio: 10 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed12
Series A20
Other Equity32

Monthly Deal Activity

Thairm Bio: 10 deals are recorded across 78 months.All available history.
Thairm Bio: 10 deals are recorded across 78 months. All available history
MonthDeals
May '201
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '211
Oct '210
Nov '210
Dec '210
Jan '221
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '231
Mar '230
Apr '230
May '230
Jun '231
Jul '230
Aug '230
Sep '231
Oct '230
Nov '230
Dec '230
Jan '241
Feb '240
Mar '240
Apr '241
May '240
Jun '240
Jul '241
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '261
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Thairm Bio: Health & Life Sciences is the largest displayed sector by deal count (10 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Thairm Bio: Health & Life Sciences is the largest displayed sector by deal count (10 deals). All available history
SectorDeals
Health & Life Sciences10
Consumer & Lifestyle2
Networks, Cloud & Communication1

Deal Size Distribution

Thairm Bio: 10 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Thairm Bio: 10 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M4
$5M-$10M2
$10M-$25M2
$25M-$50M2
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Thairm Bio: Europe has the largest recorded deal count among the displayed regions (8 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Thairm Bio: Europe has the largest recorded deal count among the displayed regions (8 deals). All available history
RegionDeals
Europe8
United States2
Thairm Bio: 10 co-investors are shown, with Scottish Enterprise sharing 7 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Thairm Bio: 10 co-investors are shown, with Scottish Enterprise sharing 7 recorded deals. All available history
Co-investorShared deals
Scottish Enterprise7
Argosy Foundation2
Kineticos Ventures2
Scottish National Investment Bank2
SIS Ventures2
UMass Amherst2
Wexford Science and Technology2
Deepbridge Capital1
Esperante1
University of Strathclyde1

Investment Strategy

Thairm Bio: Led accounts for 60% and participating for 40% of round participation.All available history.
Thairm Bio: Led accounts for 60% and participating for 40% of round participation. All available history
CategoryDeals (count)Share (%)
Led660%
Participating440%
Thairm Bio: Single-lead accounts for 67% and co-led for 33% of lead dynamics.All available history.
Thairm Bio: Single-lead accounts for 67% and co-led for 33% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead467%
Co-led233%

Team

No team members found for this fund.